Eli Lilly and Nvidia are partnering to build what the companies call the pharmaceutical industry's "most powerful" supercomputer and so-called AI factory to help accelerate drug discovery and ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern Medical Research Laboratory. Scientific Lab, Drug Engineering Center Full of ...
Regina Barzilay is a School of Engineering Distinguished Professor of AI & Health in the department of computer science and the AI faculty lead at MIT Jameel Clinic. She develops machine learning ...
A corridor at Insilico Medicine’s Robotics Lab in Suzhou, China. Insilico will partner with Eli Lilly on an artificial intelligence (AI) based drug development collaboration that they said could ...
Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...
New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...
In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery. Publishing in Trends in Pharmacological Sciences, their recommendations ...
In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development. Science and technology editor Eric Smalley interviewed Jeffrey Skolnick, eminent scholar in ...
Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual events include structured poster discussion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results